Re-examining the Therapeutic Potential of Nicotine Agents and the Venom-COVID-19 Connection
by John Fisher, PhD (assisted by AI)
Nicotine, often stigmatized as a highly addictive substance, is presented by Dr. Bryan Ardis as a powerful, non-addictive therapeutic agent that has been deliberately suppressed by health authorities. Citing published research, he posits that nicotine has the potential to treat a wide array of conditions, ranging from neurodegenerative disorders like Parkinson's and Alzheimer's to inflammatory conditions and symptoms of Long-Haul COVID-19. Notably, in the context of persistent post-viral symptoms, case studies demonstrated a complete disappearance of Long-Haul COVID-19 symptoms in participants using nicotine patches, with the rationale being that nicotine can successfully dislodge snake venom-like spike proteins from the body's nicotine receptors.
Research from early in the COVID-19 pandemic suggested a "smoker's paradox," where active smokers appeared to be underrepresented among patients with COVID-19, leading to the idea that smoking or nicotine might be protective.
Specific studies and findings related to a potential protective effect:
Infection Rates:
A French study found that among 480 patients who tested positive for the virus, only 4.4% of those admitted to the hospital were regular smokers, suggesting they were much less likely to develop a symptomatic or severe infection compared with the general population.
The French study authors claimed the protective effect for ambulatory patients divided the risk of getting infected by five, and for hospitalized patients, by four.
A study in China suggested that only 12.6% of 1,000 people infected with the virus were smokers, while the smoking rate in China's general population is around 28%.
A large-scale retrospective cohort study on a naval vessel found that current smoking status was associated with a lower risk of developing COVID-19 (Odds Ratio (OR) of 0.64 in multivariable analysis).
A meta-analysis of 233 studies found current smokers, compared with never smokers, were at a reduced risk of testing positive for SARS-CoV-2 infection (Relative Risk (RR) = 0.74).
Mortality/Severity (Nicotine Replacement Therapy):
A large study of hospitalized COVID-19 patients found that prescriptions for nicotine patches, lozenges, or gum were associated with reduced mortality among current smokers. Specifically, smokers prescribed Nicotine Replacement Therapy (NRT) had a significantly lower mortality rate (4.5%) compared to smokers who did not receive NRT (7.7%). The researchers hypothesized that nicotine may activate anti-inflammatory mechanisms.
Nicotine Research Summary and Potential Benefits
Dr. Bryan Ardis's research, as presented in chapter 13 of his book, centers on two main, interconnected arguments:
Nicotine is a powerful healing agent and is not the main addictive chemical in tobacco products. He contends that a "massive propaganda campaign" has been launched to demonize nicotine.
Addiction Misconception: Citing a Harvard study, he argues that nicotine has "poor reinforcing effects (addictive effects) when administered alone". He asserts that tobacco companies added a highly addictive, man-made chemical called Pyrazines to tobacco products starting in the early 1970s to increase sales, and that Pyrazines—not nicotine—are responsible for the intense addictive properties and high relapse rates.
Healing Power: Nicotine is presented as a miraculous compound found in the tobacco plant and common vegetables.
Nicotine is an effective antidote against "venomous COVID-19-spike proteins." This theory is based on the idea that COVID-19's spike proteins are nearly identical to neurotoxins found in King Cobra and krait snake venom.
Mechanism of Action: These venoms, and the "spike proteins," bind tightly and specifically to nicotine receptors in the body, particularly in the brain. Nicotine, when introduced, is proposed to release these venom/spike proteins, allowing normal signaling to resume. This mechanism is offered as the reason why smokers were an active group least infected and hospitalized for COVID-19.
⚕️ Conditions Nicotine May Help (According to Dr. Ardis)
Dr. Ardis asserts that nicotine has the potential to prevent, reverse, or cure numerous conditions, often providing links to published studies that he believes confirm these benefits:
COVID-19 and Related Symptoms
Lingering COVID-19 Symptoms (Long-Haul COVID-19): Complete disappearance of symptoms in days for 100% of participants in a case study using 7 mg patches.
Loss of Taste and Smell: Nicotine releases the venom spike proteins blocking the olfactory nerve, restoring the ability to transmit signals for smells and tastes.
Tinnitus (Ringing in the Ears).
POTS (Postural Orthostatic Tachycardia Syndrome): His wife's symptoms disappeared after three days of chewing nicotine gum.
Neurological and Cognitive Conditions
Parkinson's Disease (PD): Nicotine administration is said to improve memory impairment and dyskinesia (uncontrollable movements).
Alzheimer's Disease (AD): Nicotine administration is said to improve cognitive impairment.
Schizophrenia: Nicotine is known to prevent, improve, and reverse it.
Autism Spectrum Disorder (ASD): Nicotine patches have been found to improve the behavior of autistic children and adults, including aggression and irritability, with dramatic improvements in social scores.
Memory Impairment: Nicotine improves memory impairment caused by sleep deprivation and hypothyroidism.
Inflammatory and Other Chronic Conditions
Chronic Inflammatory Diseases: Nicotine is believed to be more anti-inflammatory than pro-inflammatory.
Arthritis: Improved or reversed inflammatory conditions.
Ulcerative Colitis.
Sepsis.
Multiple Sclerosis (MS): Nicotine has a proven ability to prevent it, with a study showing a significantly lower risk for those who used both smoking and snuff.
Cancer (Glial Blastoma): Nicotine alone dissolved brain "turbo cancers" by half the size in less than 72 hours in animal studies.
Type 1 Diabetes: Nicotine can protect against and improve or even reverse Type 1 Diabetes in some cases in mouse models, reducing high blood sugar (hyperglycemia) and protecting pancreatic insulin content.
👨⚕️ Dr. Ardis's Recommendations for Nicotine Use
Dr. Ardis suggests that people considering nicotine should consult their doctor and offers the following recommendations for those who choose to proceed:
Consult Resources: He directs readers to a free document simply titled "NICOTINE" in the Patient Resources Section of his website,
thedrardisshow.com, for information on how to begin using nicotine agents and personal brand recommendations.Starting Dose: For most people, he suggests starting with small doses like 1-3 mg daily for the first week before increasing to higher doses.
Personal Use: He personally buys 21 mg patches and cuts them into six equal pieces (roughly 3-4 mg size), which he wears every single day and intends to continue for the rest of his life.
Delivery Methods: He encourages exploring nicotine patches, nicotine gum, nicotine pouches, or even eating nicotine-rich vegetables.
Nicotine-Rich Vegetables: Vegetables that contain nicotine include: eggplant, zucchini, green tomatoes, cauliflower, white potatoes, red tomatoes, bell peppers, and celery. Eggplants are noted as having the second highest amount of nicotine of any plant on earth.
Conclusion
Dr. Ardis encourages individuals to investigate the wealth of information confirming nicotine's healing qualities. He personally recommends starting with a small dose, such as a 7 mg patch, or by cutting a 21 mg patch into six pieces to achieve a daily dose of roughly 3-4 mg. While commercial products like Tolevita patches are primarily marketed for smoking cessation, their availability in multiple doses, including the smaller 7 mg size, provides a straightforward path for those who, like Dr. Ardis, believe in the non-addictive, therapeutic application of nicotine for conditions such as chronic inflammation, cognitive decline, or persistent post-COVID symptoms. As with any therapeutic intervention, individuals are strongly advised to consult their doctor to determine if nicotine patches, gum, pouches, or nicotine-rich vegetables are appropriate for their specific health needs.
For individuals seeking to explore this documented healing potential, commercially available products, such as Tolevita Anti-Smoke Herbal Patches, which are available in 7 mg, 14 mg, and 21 mg strengths, offer a practical, over-the-counter means to administer a controlled dose of nicotine.
Important Context:
It is crucial to note that the majority of public health organizations and later, larger meta-analyses concluded that smoking is a risk factor for severe COVID-19 and death, particularly for current and former smokers who contract the disease. The studies suggesting a protective effect often focus on the rate of infection or hospitalization and must be viewed with caution due to inconsistencies in the data and the known severe risks of tobacco use on overall health.
Reference:Ardis, Bryan. (2024). Moving beyond the Covid-19 lies: restoring Health & hope for humanity
Hashtags: #NicotineAntidote #COVIDLies #NicotineReceptors #Pyrazines #DrBryanArdis
No comments:
Post a Comment